A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age
- Resource Type
- Article
- Source
- In
Vaccine 27 June 2017 35(30):3749-3759 - Subject
- Language
- ISSN
- 0264-410X